Drug Type Biosimilar, Enzyme |
Synonyms Yizhentong, 天力通, 宜真通 |
Target |
Mechanism PLG stimulants(Plasminogen stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ischemic stroke | Phase 3 | CN | 26 Oct 2022 | |
Ischemic stroke | Phase 3 | CN | 26 Oct 2022 | |
Pulmonary Embolism | Phase 2 | CN | 07 Nov 2023 | |
Pulmonary Embolism | Phase 2 | CN | 07 Nov 2023 | |
Acute Ischemic Stroke | IND Approval | CN | 07 Sep 2023 |